» Articles » PMID: 40087773

A Single-nucleus and Spatial Transcriptomic Atlas of the COVID-19 Liver Reveals Topological, Functional, and Regenerative Organ Disruption in Patients

Abstract

Background: The molecular underpinnings of organ dysfunction in severe COVID-19 and its potential long-term sequelae are under intense investigation. To shed light on these in the context of liver function, we perform single-nucleus RNA-seq and spatial transcriptomic profiling of livers from 17 COVID-19 decedents.

Results: We identify hepatocytes positive for SARS-CoV-2 RNA with an expression phenotype resembling infected lung epithelial cells, and a central role in a pro-fibrotic TGFβ signaling cell-cell communications network. Integrated analysis and comparisons with healthy controls reveal extensive changes in the cellular composition and expression states in COVID-19 liver, providing the underpinning of hepatocellular injury, ductular reaction, pathologic vascular expansion, and fibrogenesis characteristic of COVID-19 cholangiopathy. We also observe Kupffer cell proliferation and erythrocyte progenitors for the first time in a human liver single-cell atlas. Despite the absence of a clinical acute liver injury phenotype, endothelial cell composition is dramatically impacted in COVID-19, concomitantly with extensive alterations and profibrogenic activation of reactive cholangiocytes and mesenchymal cells.

Conclusions: Our atlas provides novel insights into liver physiology and pathology in COVID-19 and forms a foundational resource for its investigation and understanding.

References
1.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

2.
Hundt M, Deng Y, Ciarleglio M, Nathanson M, Lim J . Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network. Hepatology. 2020; 72(4):1169-1176. PMC: 9258788. DOI: 10.1002/hep.31487. View

3.
Marjot T, Webb G, Barritt 4th A, Moon A, Stamataki Z, Wong V . COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol. 2021; 18(5):348-364. PMC: 7945972. DOI: 10.1038/s41575-021-00426-4. View

4.
Wanner N, Andrieux G, Badia-I-Mompel P, Edler C, Pfefferle S, Lindenmeyer M . Molecular consequences of SARS-CoV-2 liver tropism. Nat Metab. 2022; 4(3):310-319. PMC: 8964418. DOI: 10.1038/s42255-022-00552-6. View

5.
Crook H, Raza S, Nowell J, Young M, Edison P . Long covid-mechanisms, risk factors, and management. BMJ. 2021; 374:n1648. DOI: 10.1136/bmj.n1648. View